Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05041192 · ClinicalTrials.gov registry record · NA
The Effects of Synaquell on Brain Function
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT05041192: Completed NA study, sponsored by Mayo Clinic.
NCT05041192 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05041192, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the dietary supplement, Synaquell (TM), for effects on brain function.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Synaquell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2021-09-03 |
| Est. Completion | 2022-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05041192
The ClinicalTrials.gov registry entry for NCT05041192 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05041192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05041192 about?
NCT05041192 is a clinical study titled "The Effects of Synaquell on Brain Function". The purpose of this study is to investigate the dietary supplement, Synaquell (TM), for effects on brain function.
What is the current status of trial NCT05041192?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2021-09-03. Estimated completion is 2022-04-22.
What interventions are being tested in trial NCT05041192?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Synaquell (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05041192?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.